A newly highlighted gut bacterium is sparking a massive pharma land grab. But who is truly profiting from this 'good health' discovery?
Forget insulin resistance. The latest research points to an immune system target for Type 2 Diabetes, signaling a seismic shift in metabolic treatment.
The gut-brain axis link to Alzheimer's is confirmed, but the real story is who profits from this microbial revolution in dementia research.
The new low-calorie, non-insulin spiking sugar is revolutionary, but the real story is who stands to lose billions from this breakthrough.
The viral 'fibremaxxing' trend is booming, but is it a health revolution or a marketing ploy masking systemic dietary failure? We dive deep.
Forget incremental tweaks; this is the hard truth about burning calories via walking and why 'expert' tips barely move the needle on weight loss.
New data reveals most US adults carry risk factors for a fatal syndrome. This isn't just about lifestyle; it’s about systemic failure in preventive health.
The push for perfect shift work health routines ignores the structural failures driving worker exhaustion. Unpacking the real cost of 24/7 economies.
Employers pushing for metabolic health benefits aren't just chasing wellness; they are strategically optimizing their workforce while subtly shifting risk. Unpacking the real agenda.